// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

- Crop Filling: artefact removal for real-world clinical neuroimaging data

Gonzalo Leal - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

- The heterogeneous amyloid-positive brain: mapping individualised patterns of atrophy in amyloid-positive Alzheimer’s disease patients using neuroanatomical normative models

Serena Verdi - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Associations between Repetitive Negative Thinking and segregation of the Anterior Salience Network amongst healthy middle-aged adults.

Cristina Solé-Padullés - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

CSF neurodegeneration biomarkers predict MTL atrophy over time in cognitively healthy older adults

Elettra Capogna - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interaction between APOE4 and lifestyle on neuroimaging biomarkers and cognition in cognitively unimpaired older adults

Francesca Felisatti - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Florbetapir

Inverse relationship between education and amyloid burden in individuals with subjective cognitive decline plus and mild cognitive impairment

Merle C. Hönig - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Relationships between cerebral tau and glucose metabolism in cognitively normal older adults.

Harry Crook - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sex differences in Actigraph-estimated versus Self-reported sleep quality and Alzheimer’s disease neuropathology among cognitively-unimpaired older adults

Chinedu T. Udeh-Momoh - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

The association of the of late-life onset psychotic symptoms with incident cognitive impairment in a cognitively normal sample.

Byron Creese - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

- Underlying clusters of NIA-AA Research Framework stage 2 criteria and their relationship with AD biomarkers in the DELCODE study

Lena Sannemann - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Associations of cortisol with neuroinflammation biomarkers in a memory clinic cohort.

Makrina Daniilidou - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebrovascular dysfunction

N/A

CSF markers of inflammation help identify tau pathology but not amyloid in a heterogenous clinical population

Sofia Michopoulou - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The association between allostatic load, Alzheimer biomarkers and cognition among patients at the Memory clinic: A longitudinal study

Dickson O. Adedeji - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Using the Integrated Cognitive Assessment (ICA) to improve the efficiency of primary care referrals to memory services

Chris Kalafatis - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

Icodextrin

Single domain antibodies as new detectors of neurotoxic Aβ42 oligomers

Liliana Napolitano - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Systems Analysis of Alzheimer’s Disease Pathway Dysregulation in Human Subjects is Recapitulated in 3D Cellular Models to Reveal P38 MAPK as a Therapeutic Target that Mitigates Tau Pathology

Pourya Naderi Yeganeh - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

- Markers of vitamin B12 status in relation to CSF biomarkers and cognitive performance

Babak Hooshmand - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Cyanocobalamin

- Cortical diffusivity associates with early neuronal damage

Joseph Nowell - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

- Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease

Luigi Lorenzini - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

A Longitudinal Analysis of Cerebral Blood Flow Changes in Genetic Frontotemporal Dementia: Results from GENFI

Maurice Pasternak - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

Copyright © 2026. QuantiNova All rights reserved